9 Common Food Allergies Explained: How Pharma Companies Are Working Toward Better Solutions 

Food allergies affect hundreds of millions of people worldwide, and the numbers keep climbing every year. Understanding the common food allergies driving this trend — and the science being developed to treat them — matters for patients, parents, and healthcare providers alike.

What Is the Most Common Allergy?

When people ask what is the most common allergy, the answer usually points to reactions triggered by a small handful of proteins found in everyday foods. These proteins can cause anything from mild hives to life-threatening anaphylaxis, which is why identifying and managing them has become a global public health priority.

9 Major Food Allergens

Regulatory bodies in the US, EU, and beyond have identified a core group known as the 9 major food allergens. These are responsible for the vast majority of allergic reactions:

1. Milk – especially in infants and young children

2. Eggs – a leading trigger in early childhood

3. Peanuts – one of the most severe and persistent allergies

4. Tree nuts (almonds, walnuts, cashews)

5. Wheat – often confused with celiac disease

6. Soy

7. Fish

8. Shellfish

9. Sesame – recently added to major labeling requirements

Together, these make up the majority of documented common allergies, and food manufacturers are now legally required to disclose them clearly on packaging.

Most Allergic Foods and Cross-Reactivity

Among the most allergic foods, peanuts and shellfish tend to cause the most severe reactions, while milk and eggs are more common but often outgrown in childhood. Cross-reactivity is another challenge — someone allergic to tree nuts may also react to certain seeds or fruits, complicating diagnosis and treatment plans.

Top 20 Food Allergies: Beyond the Big Nine

While the nine major allergens dominate clinical attention, researchers tracking the top 20 food allergies point to additional culprits such as mustard, celery, lupin, mollusks, kiwi, and specific spices. These lesser-known triggers are gaining recognition as diagnostic tools improve and reporting becomes more standardized across countries.

Alergias Alimentarias Raras: A Global Perspective

Interestingly, patterns vary by region. In Spanish-speaking countries, discussions around alergias alimentarias raras highlight allergies to foods like lentils, chickpeas, and certain fruits that are far less prevalent in North America or Northern Europe. This regional variation underscores that allergy profiles are shaped as much by diet and genetics as by biology alone.

Common Allergens in Food Manufacturing

For food producers, managing common allergens means strict facility controls, dedicated production lines, and rigorous label accuracy. A single trace of an undeclared allergen can trigger a recall — and, more importantly, put consumers at serious risk.

How Pharma Companies Are Tackling the Crisis

The pharmaceutical industry has responded to rising allergy rates with several breakthrough approaches:

• Oral immunotherapy (OIT): Companies have developed FDA-approved treatments that gradually desensitize patients — particularly children — to peanut proteins through controlled, incremental exposure.

• Biologic therapies: Monoclonal antibodies originally developed for asthma are now being repurposed to reduce the severity of allergic reactions across multiple food triggers simultaneously.

• Epinephrine innovation: New auto-injector formats and nasal spray alternatives are making emergency treatment faster and less intimidating, especially for children and needle-averse patients.

• Diagnostic advances: Component-resolved diagnostics now allow doctors to pinpoint the exact protein responsible for a reaction, reducing unnecessary dietary restrictions.

• Vaccine research: Several biotech firms are in early trials for preventive vaccines aimed at reducing allergy development in high-risk infants.

The Road Ahead

As awareness grows, so does investment. Pharmaceutical and biotech companies are pouring resources into therapies that don't just manage symptoms but aim to retrain the immune system entirely. Combined with better labeling, improved diagnostics, and increased public education, the outlook for allergy sufferers is steadily improving — even as the prevalence of these conditions continues to rise across the globe.

Food allergies remain a serious and growing health challenge, but the combination of regulatory action, manufacturing accountability, and pharmaceutical innovation offers real hope for safer, more manageable futures for millions of patients.

Latest Reports Offered by Delveinsight

keloid market, medical sterilization equipment market, negative pressure wound therapy npwt devices market, neuronal ceroid-lipofuscinoses market, neurovascular catheters market, neurovascular devices market, opioid use disorder market, post operative pain market, richter syndrome market, severe dry eye market, surgical stapling devices market, tumor ablation market, urinary incontinence devices market, ventricular fibrillation market, wolman disease market, adamantinoma market, ambulatory arrhythmia monitoring devices market, bone resorption market, burn market, carpal tunnel syndrome market, chronic pain market, coronary guidewires market, cough assisted device market, dystrophic epidermolysis bullosa market, gall bladder cancer market, gene and cell therapies in rare disorder market, 

About Delveinsight

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Contact Us

Kanishk

kkumar@delveinsight.com